News & Press Releases
Filter by:
Biotech Startups, VCs Seek Path Forward After A Bruising Year
January 12, 2023
Mintz Member Joshua Fox spoke to the Wall Street Journal about what's ahead for biotech startups and venture capitalists following a difficult year.
In Recession Planning, Firms See 'Opportunities' And 'Challenges'
January 11, 2023
The American Lawyer highlighted Mintz's planned move into the Miami market and quoted Managing Member Bob Bodian and Corporate & Securities Member Jim Ball on the firm's expansion.
MoCRA- Industry Must Prepare For Mandatory Adverse Event Reporting And Safety Substantiation Now: Expert
January 11, 2023
Mintz Member Joanne Hawana and Associate Jean Krebs were interviewed by CosmeticDesign about legal reform in the U.S. Food and Drug Administration.
Mintz Member Joshua Fox spoke to Forbes about the logistics of Shark Tank and how deal terms develop after filming.
Mintz Advises Bio Client Asimov in $200M Fundraising
January 10, 2023
Mintz advised Asimov in a $200 million fundraising aimed at helping the synthetic biology company scale its tools and services business focused on biologics, cell and gene therapies, and RNA. Mintz Member and seasoned life sciences transactional attorney Joshua Fox led a team that included Associates Kaoru Suzuki and Michael Katz.
Mintz Guides QIAGEN In Its $150 Million Purchase Of Verogen
January 09, 2023
